Next is Now.

October 3, 2010

US apologizes for ’40s syphilis study in Guatemala

WASHINGTON – American scientists deliberately infected prisoners and patients in a mental hospital in Guatemala with syphilis 60 years ago, a recently unearthed experiment that prompted U.S. officials to apologize Friday and declare outrage over “such reprehensible research.” However, The Tuskegee Syphilis Study is one of the most horrendous examples of research carried out in disregard of basic ethical principles of conduct. The publicity surrounding the study was one of the major influences leading to the codification of protection for human subjects.

In 1928, the director of medical services for the Julius Rosenwald Fund, a Chicago-based charity, approached the U.S. Public Health Service (PHS) to consider ways to improve the health of African Americans in the South. At the time, the PHS had just finished a study of the prevalence of syphilis among black employees of the Delta Pine and Land Company of Mississippi. About 25% of the sample of over 2000 had tested positive for syphilis.

The PHS and the Rosenwald fund collaborated in treating these individuals. Subsequently, the treatment program was expanded to include five additional counties in the southern U.S.: Albemarle County, Virginia; Glynn County, Georgia; Macon County, Alabama; Pitt County, North Carolina; and Tipton County, Tennessee (Jones, 1981).

During the set-up phase of the treatment program, the Great Depression began. The Rosenwald Fund was hit hard and had to withdraw its support. Without the Rosenwald Fund, the PHS did not have the resources to implement treatment.

During this period, there was a debate occurring in health circles about possible racial variation in the effects of syphilis. Dr. Taliaferro Clark of the PHS suggested that the project could be partially “salvaged” by conducting a prospective study on the effects of untreated syphilis on living subjects. Clark’s suggestion was adopted.

In the beginning stages of the project, the PHS enlisted the support of the Tuskegee Institute. Since the Tuskegee Institute had a history of service to local African Americans, its participation increased the likelihood of the “success” of the experiment. In return, Tuskegee Institute received money, training for its interns, and employment for its nurses. In addition, the PHS recruited black church leaders, community leaders, and plantation owners to encourage participation.

At the time of the project, African Americans had almost no access to medical care. For many participants, the examination by the PHS physician was the first health examination they had ever received. Along with free health examinations, food and transportation were supplied to participants. Thus, it was not difficult to recruit African American men as participants in the study. Burial stipends were used to get permission from family members to perform autopsies on study participants (Jones, 1981).

While study participants received medical examinations, none were told that they were infected with syphilis.

July 1, 2010

AMERICAN GREED

Federal health officials pushed five vaccine manufacturers to quickly produce a vaccine. They wanted a lot of it. About a quarter of the swine flu vaccine produced for the U.S. public has expired — meaning that a whopping 40 million doses worth about $260 million are being written off as trash. Why produce so much? The problem is greed. Corporate profits have become more important than honor and integrity.

May 16, 2010

misleading drug ads

Big Bucks, Big Pharma. The real war on drugs!

Currently the FDA relies on a few dozen staffers to review hundreds of pharmaceutical ads, brochures and presentations voluntarily submitted by companies or reported to the agency by drug industry personnel. 

The drug industry’s lobbying group said in a statement it supported the effort as “another step to help educate — and receive feedback from — health care providers about prescription drug advertising and promotion.”

The lobbying group, Pharmaceutical Research and Manufacturers of America, represents most of the world’s largest drugmakers, including Pfizer, Merck & Co. and GlaxoSmithKline.

Drugmakers spend about $20 billion per year to promote their products in various mediums, ranging from medical journal ads and information booths at conferences to multimillion dollar TV campaigns.

About $4 billion of industry spending goes toward patient-targeted advertisements. Some drug industry critics charge TV drug advertisements encourage over-prescribing of medications by emphasizing the benefits and minimizing the risks.

May 9, 2010

Psychiatry: An Industry of Death

Psychiatry: An Industry of Death. The major pharmaceutical companies are big backers of the Drug War… It’s not that they don’t want us on drugs – they just want us on theirs.

May 6, 2010

Prescription for Disaster

Filed under: greed,health care,lobbying,manipulation — greedygreg @ 1:54 am
Tags: , , ,

Prescription for Disaster. It is estimated that in America last year, nearly $2 trillion was spent on health care — and virtually all that money was spent on treating disease.

Each year more money is spent on treatment, mere patchwork, even though it has become crystal-clear that treatments do NOT enable you to live a longer, better life. So why is the amount of money being spent on prevention just a pittance compared with the amount spent on treatment?

“Prescription for Disaster” is an in-depth investigation into the symbiotic relationships between the pharmaceutical industry, the FDA, lobbyists, lawmakers, medical schools, and researchers, and the impact this has on American consumers and their health care. During this thorough investigation, the film takes a close look at patented drugs, why they are so readily prescribed by doctors, the role insurance companies and HMO’s play in promoting compliance, and the problem of rising health care costs. It examines the marketing and public relations efforts on behalf of the pharmaceutical companies, including sales reps, medical journals and conferences. Further, the film looks at alternatives to traditional pharmacology and drug therapy, such as vitamins and nutritional supplements, and why they are often perceived as a competitive threat to the drug manufacturers. Alternative therapies also include diet, exercise and a healthy lifestyle.

This documentary takes you on a journey through the tangled web of big business, the way disease is treated today, and the consequences we suffer as a society.

March 5, 2010

Republican National Committee

Leaked documents reveal  plan to use scare tactics to raise money. Michael Steele,Chairman of the Republican National Committee  flies in private aircraft. He drives in private cars. He has private consultants that are paid ridiculous retainers,by using other people’s money.”( YOURS}where the human mind is drilled and manipulated into submission to various social and moral spooks, and thus fitted to continue our system of exploitation and oppression…….Selling fear to the American people has become a mainstay of RP(Republican party) . The memo candidly confirms that the aim of such caricature is to amp up {fear} “ stopping the Obama/Pelosi/Reid agenda.”

February 26, 2010

Obama rebuffs McCain: ‘The election is over,B**ch!

Filed under: Democrat,government,health care,insurance,Republican — greedygreg @ 1:14 am
Tags: ,

 Sen. John McCain angrily told President Obama to “start over”  citing  his health care and federal deficit plans need to be re- negotiated.  Obama  simply said ” John,The U.S. federal debt has not been paid off since the days of Andrew Jackson. Only the interest gets paid, while the principal portion continues to grow. I think you and your party would agree that

February 15, 2010

Foreclosures

While we talk of recovery, the personal pain of poverty is all around us. Some seeds of today’s troubles were sown by the responses – or lack of them – to the financial crises. January represented the 11th straight month of more than 300,000 properties receiving foreclosure filings in the country, according to Irvine-based RealtyTrac, which is predicting a record 3 million foreclosures this year.  Some lawmakers have profited from investments in companies that have received federal bailouts; dozens of lawmakers are invested in Wells Fargo, Citigroup, Goldman Sachs and Bank of America. Senate Minority Leader Mitch McConnell (R-Ky.) gained about $9.2 million. Sen. James Inhofe (R-Okla.) gained about $3 million, Sen. Daniel Inouye (D-Hawaii) had an estimated $2.6 million gain, and Richard Shelby (R-Ala.) gained about $2.8 million. I bet that no one on this list home is in foreclosure!

February 12, 2010

WellPoint insurance hike becomes target for Obama

To President Barack Obama, however, it’s Exhibit A in his campaign to revive the health care overhaul.

Health and Human Services Secretary Kathleen Sebelius, who received the company’s explanation in a letter Thursday, said “it remains difficult to understand” how premium increases of that size by can be justified when WellPoint Inc. reported a $2.7 billion profit in the last quarter of 2009.

Majority leader Harry Reid, D-Nev., went further. In a speech on the Senate floor, he attacked WellPoint and other “greedy insurance companies that care more about profits than people.”

“They get rich while people who already can barely afford their coverage lose their coverage altogether,” Reid said.

 

WELLPOINT INC.

(RT-BATS: WLP)

Last Trade: 60.52
 
 KEY EXECUTIVES at Wellpoint insurance Pay Exercised
Ms. Angela F. Braly , 48
Chief Exec. Officer, Pres, Director and Member of Exec. Committee
$ 1.21M $ 0
Mr. Wayne S. Deveydt , 40
Chief Financial Officer, Chief Staff Officer, Exec. VP and Head of Investor Relations
$ 676.00K $ 0
Mr. Ken R. Goulet , 50
Exec. VP, Chief Exec. Officer of Commercial Bus. Unit and Pres of Commercial Bus. Unit
$ 676.00K $ 218.00K
Ms. Dijuana K. Lewis , 51
Exec. VP, Chief Exec. Officer of Comprehensive Health Solutions Bus. Unit and Pres of Comprehensive Health Solutions Bus. Unit
$ 651.00K $ 0
Mr. Bradley M. Fluegel , 49
Chief Strategy & External Affairs Officer and Exec. VP
$ 539.00K
INSIDER TRANSACTIONS REPORTED
Date Insider Shares Type Transaction Value*
9-Feb-10 MAYS WILLIAM G
Director
50,000 Direct Option Exercise at $35.85 – $44.18 per share. N/A
9-Feb-10 MAYS WILLIAM G
Director
31,200 Direct Sale at $60.97 per share. $1,902,264
9-Feb-10 BUSH WILLIAM H T
Director
3,056 Direct Option Exercise at $6.34 per share. $19,375
9-Feb-10 BUSH WILLIAM H T
Director
3,056 Direct Sale at $61.12 – $61.13 per share. $187,0002
5-Feb-10 BURKE SHEILA P
Director
9,920 Direct Option Exercise at $25.61 per share. $254,051
5-Feb-10 BURKE SHEILA P
Director
9,920 Direct Sale at $62 per share. $615,040
4-Feb-10 RIEGLE DONALD W JR
Director
5,000 Direct Option Exercise at $44.18 per share. $220,900
4-Feb-10 RIEGLE DONALD W JR
Director
5,000 Direct Sale at $63.60 per share. $318,000
3-Feb-10 BEER LORI A
Officer
20,910 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 SASSI BRIAN A
Officer
26,137 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 MILLER CYNTHIA S
Officer
20,910 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 CANNON JOHN
Officer
20,910 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 LEWIS DIJUANA K
Officer
26,137 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 FLUEGEL BRADLEY M
Officer
20,910 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 GOULET KENNETH R
Officer
31,366 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 MILLER MARTIN L
Officer
8,625 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 BRALY ANGELA F
Officer
97,233 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 DEVEYDT WAYNE S
Officer
26,137 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 BROWN RANDAL L
Officer
20,910 Direct Acquisition (Non Open Market) at $0 per share. N/A
3-Feb-10 NUSSBAUM SAMUEL R MD
Officer
20,910 Direct Acquisition (Non Open Market) at $0 per share. N/A
20-Jan-10 GLASSCOCK LARRY C
Director
18,333 Direct Option Exercise at $44.18 per share. $809,951
20-Jan-10 GLASSCOCK LARRY C
Director
18,333 Direct Automatic Sale at $67.62 – $69.56 per share. $1,257,0002
7-Jan-10 GLASSCOCK LARRY C
Director
18,333 Direct Option Exercise at $44.18 per share. $809,951
7-Jan-10 GLASSCOCK LARRY C
Director
18,333 Direct Automatic Sale at $62.33 – $63.66 per share. $1,155,0002
4-Jan-10 CANNON JOHN
Officer
601 Direct Disposition (Non Open Market) at $59.75 per share. $35,909

Theme: Rubric. Blog at WordPress.com.

Follow

Get every new post delivered to your Inbox.